Literature DB >> 11379821

Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules.

C G Eberhart1, W E Kaufman, T Tihan, P C Burger.   

Abstract

Nodular/desmoplastic medulloblastomas are a well-established histopathological subtype containing reticulin-free nodules or "pale islands' that are comprised of cells with round "neurocytic" nuclei and abundant cytoplasm. Significant neuronal maturation occurs within nodules. We used immunohistochemistry to evaluate neuronal differentiation in the nodules of 6 of these tumors. The neuronal markers NeuN, synaptophysin, and MAP-2 were identified in the "pale islands" of all 6 nodular medulloblastomas examined, and high and medium molecular weight nonphosphorylated neurofilaments were detected in 2 of the 6 cases. We also observed collections of apoptotic cells within nodules. Given the known role of neurotrophin signaling in neuronal maturation and apoptosis, we analyzed immunohistochemically the distribution of neurotrophin receptors TrkA and TrkC and their primary ligands NGF and NT3 in 14 nodular medulloblastomas. TrkA and TrkC were detected in 13 and 10 cases, respectively, and were predominantly localized within nodules. NGF and NT3 were distributed diffusely with some nodular accentuation. The localized expression of Trk receptors within nodules of desmoplastic medulloblastomas suggests neurotrophin signaling is involved in the apoptosis and neuronal differentiation in medulloblastomas. We also examined expression of p53 and BCL-2 in these tumors; both were prominent in internodular regions but only weakly expressed within nodules. Trk receptors, p53, and BCL-2 are all expressed during development of the normal cerebellum. Interestingly, the immunohistochemical expression profile of these proteins in the differentiating nodules of medulloblastomas is in many ways similar to their expression in the developing cerebellum. Thus similar signaling pathways may be operational in cerebellar development and medulloblastoma tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379821     DOI: 10.1093/jnen/60.5.462

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

Review 1.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

2.  Hedgehog signaling promotes medulloblastoma survival via Bc/II.

Authors:  Eli E Bar; Aneeka Chaudhry; Mohamed H Farah; Charles G Eberhart
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.

Authors:  Roger E McLendon; Adesina Adekunle; Veena Rajaram; Mehmet Koçak; Susan M Blaney
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

4.  Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.

Authors:  Carsten Friedrich; Tarek Shalaby; Christoph Oehler; Martin Pruschy; Burkhardt Seifert; Daniel Picard; Marc Remke; Monika Warmuth-Metz; Rolf-Dieter Kortmann; Stefan Rutkowski; Michael A Grotzer; André O von Bueren
Journal:  Childs Nerv Syst       Date:  2017-07-10       Impact factor: 1.475

5.  Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans.

Authors:  J Pöschl; A Lorenz; W Hartmann; A O von Bueren; M Kool; S Li; A Peraud; J-C Tonn; J Herms; M Xiang; S Rutkowski; H A Kretzschmar; U Schüller
Journal:  Oncogene       Date:  2011-05-23       Impact factor: 9.867

6.  INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.

Authors:  Heather M Ames; Lisa M Rooper; John J Laterra; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  2018-05-01       Impact factor: 3.685

Review 7.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

8.  MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study.

Authors:  Fabio Rotondo; Kenichi Oniya; Kalman Kovacs; C David Bell; Bernd W Scheithauer
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

9.  Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.

Authors:  Mandy J Binning; Toba Niazi; Carolyn A Pedone; Bachchu Lal; Charles G Eberhart; K Jin Kim; John Laterra; Daniel W Fults
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas.

Authors:  Antonio Chiaretti; Luigi Aloe; Alessia Antonelli; Antonio Ruggiero; Marco Piastra; Riccardo Riccardi; Giampiero Tamburrini; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-05-06       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.